Thyroid Tablet Recall: Superpotent Batch | Denver News

Vitruvias Therapeutics is recalling a specific batch of thyroid tablets—lot 504950—because they’re dangerously “superpotent,” containing too much active ingredient and risking hyperthyroidism. Symptoms include weight loss, heat intolerance, anxiety, and even heart issues—especially risky for seniors, pregnant women, and infants. No adverse reports yet, but the company is urgently pulling the product from shelves and advising patients to consult their doctors before stopping treatment. Distributed between Jan 31, 2025, and Sept 30, 2025, about 1,955 units were sold; direct outreach is underway. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0f98f80f1ef9c4e6